FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013221408> ?p ?o ?g. }

• W2013221408 endingPage "404" @default.
• W2013221408 startingPage "397" @default.
• W2013221408 abstract "Epigallocatechin gallate (EGCG) has exhibited antitumor properties against bladder cancer. However, its effects in interstitial cystitis (IC) have not been investigated.Here, we performed repeated cystoscopy and re-biopsy of bladder mucosa before and after intravesical irrigation of EGCG in eight patients diagnosed with IC based on clinical and histopathologic assessments. Six normal bladder tissue samples were obtained from age-, race-, and sex-matched asymptomatic control subjects. IC symptom index was used to compare the therapeutic effect in IC patients. Patient-derived bladder epithelial cells were cultured and cell stretch experiments and ATP assays were performed. The expression of purinergic receptors X1, X2, and X3, and Y1, Y2, and Y11, in biopsied samples was detected by Western blotting and real-time polymerase chain reaction, respectively. Moreover, the expression of inducible NO synthase, phosphorylated Akt, and phosphorylated NF-κB was also assessed.All EGCG-treated patients demonstrated different extents of remission of symptoms. We found a significant upregulation in P2X1, P2X2, and P2X3 receptor proteins and P2Y1, P2Y2, and P2Y11 receptor transcripts in IC patients. However, EGCG therapy attenuated the expression of all purinergic receptors. In addition, EGCG demonstrated prominent antioxidative and antiinflammatory effects via inhibition of the upregulation of iNOS and phosphorylated NF-κB. Furthermore, the stretch-activated release of ATP in cultured bladder urothelial cells was greater in cells derived from IC patients, compared with those from the control patients, but EGCG, at all concentrations tested, effectively abolished the increase in ATP release from stretched IC patient-derived cells.Our study suggests that inhibition of the expression of purinergic receptors and ATP release in urothelial cells by EGCG supports further development of EGCG as a novel therapeutic option for IC." @default.
• W2013221408 created "2016-06-24" @default.
• W2013221408 creator A5005878751 @default.
• W2013221408 creator A5006799132 @default.
• W2013221408 creator A5010729427 @default.
• W2013221408 creator A5028285167 @default.
• W2013221408 creator A5036436436 @default.
• W2013221408 creator A5059986506 @default.
• W2013221408 creator A5060231540 @default.
• W2013221408 creator A5082970404 @default.
• W2013221408 creator A5086461976 @default.
• W2013221408 date "2013-07-01" @default.
• W2013221408 modified "2023-09-28" @default.
• W2013221408 title "Epigallocatechin gallate attenuates interstitial cystitis in human bladder urothelium cells by modulating purinergic receptors" @default.
• W2013221408 cites W1420156288 @default.
• W2013221408 cites W1581192104 @default.
• W2013221408 cites W1597875543 @default.
• W2013221408 cites W1893308746 @default.
• W2013221408 cites W1904796894 @default.
• W2013221408 cites W1996160243 @default.
• W2013221408 cites W2007204309 @default.
• W2013221408 cites W2017920747 @default.
• W2013221408 cites W2019370739 @default.
• W2013221408 cites W2020730293 @default.
• W2013221408 cites W2025853810 @default.
• W2013221408 cites W2039328745 @default.
• W2013221408 cites W2053799309 @default.
• W2013221408 cites W2063660173 @default.
• W2013221408 cites W2070216091 @default.
• W2013221408 cites W2098273035 @default.
• W2013221408 cites W2105392824 @default.
• W2013221408 cites W2123066677 @default.
• W2013221408 cites W2139711589 @default.
• W2013221408 cites W2168556036 @default.
• W2013221408 cites W2418984024 @default.
• W2013221408 cites W4240162654 @default.
• W2013221408 doi "https://doi.org/10.1016/j.jss.2012.11.041" @default.
• W2013221408 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23260235" @default.
• W2013221408 hasPublicationYear "2013" @default.
• W2013221408 type Work @default.
• W2013221408 sameAs 2013221408 @default.
• W2013221408 citedByCount "15" @default.
• W2013221408 countsByYear W20132214082013 @default.
• W2013221408 countsByYear W20132214082014 @default.
• W2013221408 countsByYear W20132214082015 @default.
• W2013221408 countsByYear W20132214082017 @default.
• W2013221408 countsByYear W20132214082018 @default.
• W2013221408 countsByYear W20132214082019 @default.
• W2013221408 countsByYear W20132214082020 @default.
• W2013221408 countsByYear W20132214082021 @default.
• W2013221408 countsByYear W20132214082022 @default.
• W2013221408 countsByYear W20132214082023 @default.
• W2013221408 crossrefType "journal-article" @default.
• W2013221408 hasAuthorship W2013221408A5005878751 @default.
• W2013221408 hasAuthorship W2013221408A5006799132 @default.
• W2013221408 hasAuthorship W2013221408A5010729427 @default.
• W2013221408 hasAuthorship W2013221408A5028285167 @default.
• W2013221408 hasAuthorship W2013221408A5036436436 @default.
• W2013221408 hasAuthorship W2013221408A5059986506 @default.
• W2013221408 hasAuthorship W2013221408A5060231540 @default.
• W2013221408 hasAuthorship W2013221408A5082970404 @default.
• W2013221408 hasAuthorship W2013221408A5086461976 @default.
• W2013221408 hasConcept C104317684 @default.
• W2013221408 hasConcept C121608353 @default.
• W2013221408 hasConcept C126322002 @default.
• W2013221408 hasConcept C127561419 @default.
• W2013221408 hasConcept C142724271 @default.
• W2013221408 hasConcept C170493617 @default.
• W2013221408 hasConcept C185592680 @default.
• W2013221408 hasConcept C2777540882 @default.
• W2013221408 hasConcept C2778508898 @default.
• W2013221408 hasConcept C2779762690 @default.
• W2013221408 hasConcept C2780352672 @default.
• W2013221408 hasConcept C2910041100 @default.
• W2013221408 hasConcept C502942594 @default.
• W2013221408 hasConcept C55493867 @default.
• W2013221408 hasConcept C57306754 @default.
• W2013221408 hasConcept C71924100 @default.
• W2013221408 hasConcept C77411442 @default.
• W2013221408 hasConceptScore W2013221408C104317684 @default.
• W2013221408 hasConceptScore W2013221408C121608353 @default.
• W2013221408 hasConceptScore W2013221408C126322002 @default.
• W2013221408 hasConceptScore W2013221408C127561419 @default.
• W2013221408 hasConceptScore W2013221408C142724271 @default.
• W2013221408 hasConceptScore W2013221408C170493617 @default.
• W2013221408 hasConceptScore W2013221408C185592680 @default.
• W2013221408 hasConceptScore W2013221408C2777540882 @default.
• W2013221408 hasConceptScore W2013221408C2778508898 @default.
• W2013221408 hasConceptScore W2013221408C2779762690 @default.
• W2013221408 hasConceptScore W2013221408C2780352672 @default.
• W2013221408 hasConceptScore W2013221408C2910041100 @default.
• W2013221408 hasConceptScore W2013221408C502942594 @default.
• W2013221408 hasConceptScore W2013221408C55493867 @default.
• W2013221408 hasConceptScore W2013221408C57306754 @default.
• W2013221408 hasConceptScore W2013221408C71924100 @default.
• W2013221408 hasConceptScore W2013221408C77411442 @default.
• W2013221408 hasFunder F4320321001 @default.
• W2013221408 hasIssue "1" @default.

• next